24.24%| YTD | 1Yr | 3Yr | 5Yr | 10Yr | |
| Fund | 24.24 | 50.64 | -5.95 | 2.20 | 4.38 |
| Classification | 25.39 | 57.00 | -8.05 | -0.01 | 3.37 |
| Index (S&P 500) | 23.50 | 48.80 | -5.90 | 0.70 | -0.90 |
| % Rank in Class (1-best,100=worst) | 44 | 55 | 25 | 14 | 36 |
| Investment Objective: | Growth & Income |
|---|---|
| Net Assets ($Mil) | 467.00 |
| Inception Date: | 11/19/90 |
| Manager Name, Tenure | Ashton/Morris/Teach, 1999 / 1990 / 1990 |
| Expense Ratio: | 0.70% |
|
Sales Charge:
Load Type:
|
No Load 0.00% 0.00% |
| Company Name | Symbol | % Net Assets |
|---|---|---|
| Abbott Laboratories | ABT | 4.62 |
| Dell Inc | DELL | 4.33 |
| Bristol Myers | BMY | 4.14 |
| Pfizer | PFE | 4.08 |
| Hospira | HSP | 3.99 |
| Intel Corp | INTC | 3.98 |
| Jpmorgan Chase | JPM | 3.71 |
| Cisco Systems Inc | CSCO | 3.61 |
| Hewlett-packard Co | HPQ | 3.37 |
| Parker-hannifin | PH | 3.34 |
| % of Total Holdings | 39.17 | |